- AlloCyte Pharmaceuticals AG (AlloCyte) is a privately held Swiss company founded in
- AlloCyte develops innovative small molecule drugs for severe immune-mediated diseases.
- AlloCyte targets one of the most powerful families of drug targets, integrins, via a novel
- AlloCyte’s activities are financed by private investors and public funds including the
Swiss Commission for Technology and Innovation (CTI).
- To find out more about AlloCyte, please contact us.